NCT04164290View on ClinicalTrials.gov

A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

April 9, 2021

Study Completion Date

April 9, 2021

Conditions

Healthy

Interventions

DRUG

Jiashen Tablets

1 tablet

DRUG

Jiashen Tablets

2 tablets

DRUG

Jiashen Tablets

4 tablets

DRUG

Jiashen Tablets

6 tablets

DRUG

Jiashen Tablets

8 tablets

DRUG

Jiashen Tablets

9 tablets

DRUG

Jiashen Tablets Placebo

1 tablet

DRUG

Jiashen Tablets Placebo

2 tablets

DRUG

Jiashen Tablets Placebo

4 tablets

DRUG

Jiashen Tablets Placebo

6 tablets

DRUG

Jiashen Tablets Placebo

8 tablets

DRUG

Jiashen Tablets Placebo

9 tablets

Trial Locations (1)

Unknown

The second affiliated hospital of tianjin university of traditional Chinese medicine, Tianjin

All Listed Sponsors

lead

Tasly Pharmaceutical Group Co., Ltd

INDUSTRY

NCT04164290 - A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter